House Democrats released the following after the measure moved out of committee, following strong opposition from the Delaware Healthcare Association, a trade association that represents the state's hospitals.
DOVER – On Wednesday, the House Administration Committee released legislation aimed at managing the alarming rise of healthcare costs by establishing greater oversight of hospitals.
Sponsored by House Speaker Valerie Longhurst, House Bill 350...
By Jacob Owens
This story was produced by Spotlight Delaware, a community-powered, collaborative, nonprofit newsroom covering the First State. Learn more at spotlightdelaware.org
Why should Delaware care?The proposal to institute a health care cost review board would be a major change in regulation for the state’s hospital system at a time when the cost of care is rising, effectively putting political...
A Delaware House committee has passed legislation that would order the state's nonprofit hospital systems to report their community benefit spending.
House Bill 326 would require hospitals to report spending on uncompensated care, support for medical research, health education and prevention programs, community clinic subsidies, and social factors that affect health, according to the bill's text.
The bill, sponsored by...
The Delaware House on Tuesday passed two bills aimed at increasing transparency in the process of selecting retirement health plans for state workers.
B 281 and HB 282, both sponsored by Rep. Paul Baumbach, D-Newark, would prohibit the state from considering Medicare Advantage plans for state retirees and make several changes to the State Employee Benefits Committee (SEBC), the group...
Incyte reported promising results from a Phase 2 of using Opzelura cream in adult patients with mild-to-moderate hidradenitis suppurativa (HS).
Results were announced at the American Academy of Dermatology Annual Meeting.
The study demonstrated a significantly greater reduction in abscess and inflammatory nodule count in patients treated with the cream.
The study results showed that ruxolitinib...
Last month, industry and government dignitaries gathered to mark the opening of Prelude Therapeutics new headquarters and research lab at the Chestnut Run Innovation & Science Park near Wilmington.
Prelude Therapeutics founder and CEO, Kris Vaddi, began the ceremony by reflecting on Prelude’s mission. “This was an idea to build a cancer-focused biotech company, rooted in science from...
A Rite Aid store in the Kent County town of Harrington is the latest on a closing list filed in U.S. Bankruptcy Court in New Jersey
The Kent County location was one of 77 stores listed in a court document and follows earlier store closings, mainly in northern Delaware..
Rite Aid filed for Chapter 11 protection due...
ChristianaCare, in partnership with a healthcare company, announced plans to open two micro-hospitals in Delaware County, PA.The partnership with Emerus Holdings Inc. comes as ChristianaCare continues work on a neighborhood hospital at the former Jennersville Hospital site in neighboring southern Chester County, PA. ChristianaCare is based in Wilmington. “We are excited to bring this new model of care to our...
Nemours Children’s Health, has agreed to an affiliation with Delaware County, PA neighbor Crozer Health.
This affiliation marks a step forward in advancing the Neonatal Intensive Care Unit and pediatric cardiology services for young patients, including newborns requiring specialized care and children with cardiac conditions.
This new affiliation will provide patients with access to Nemours’ services, while...
The Beebe Medical Foundation announced that it had received its second-largest philanthropic gift in Beebe Healthcare’s 108-year history from bank owner Rocco and Mary Abessinio and their family.
Beebe Healthcare will name its Rehoboth Health Campus as the “Abessinio Health Campus." The campus is located on John J. Williams Highway and Warrington Road between Lewes and Rehoboth...
A late stage trial pointed to AstraZeneca’s Tagrisso prolonging the lives of patients with a type of lung cancer.
Overall survival data showed a favorable trend for Tagrisso, although data were not complete at the time of this analysis. The trial will continue. The drug was previously approved for patients with certain types of non small cell...
A former chief marketing officer for a New Castle-based pharmacy company has agreed to settle a whistleblower case involving kickbacks to physicians and waiving co-pays on federal healthcare programs such as Medicare.
Carla Sparkler, former Chief Marketing Officer of BioTek reMEDys Inc. agreed to a a six-year federal healthcare exclusion, which will prohibit her from participating in any federally funded health...
The announcement that AstraZeneca will spend $300 million on a cancer cell therapy research and development site outside Washington, DC, came with a Wilmington dateline. That's because the UK-based pharmaceutical company has its US headquarters in Talleyville, just outside Wilmington.
AZ is celebrating its 25th anniversary this year, an occasion noted by CEO Sir Pascal Soriot in an upbeat year-end...
Incyte signed an asset purchase agreement with MorphoSys, which gives Incyte exclusive global rights for tafasitamab, marketed as Monjuvi in the U.S.
“This new agreement with MorphoSys provides Incyte with exclusive global rights to tafasitamab and full control over its development and commercialization, allowing us to realize significant operating efficiencies and cost synergies,” said Hervé Hoppenot, Incyte...
Cortado Ventures, an investment firm announced a strategic investment in CorriXR Therapeutics, a cance-focused biotherapeutics development company with gene editing platform technology.
The dollar amount of the investment from the Oklahoma City company was not disclosed.
This investment solidifies Cortado’s commitment to advancing cutting-edge medical solutions and supporting the development of groundbreaking treatments for cancer, a release stated.
CorriXR...